ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: communication

A World of Difference: Updates from the Global Rheumatology Summit

Jason Liebowitz, MD, FACR  |  January 20, 2023

The second annual Global Rheumatology Summit focused on climate change, conflict and migration, as well as other global issues in rheumatology.

Filed under:ACR ConvergenceConditionsMeeting ReportsMyositis Tagged with:ACR Convergence 2022Global Rheumatology Summitidiopathic inflammatory myositisMentorshippatient accessWorkforce

In Memoriam: A Tribute to Dr. Philip Robinson

The COVID-19 Global Rheumatology Alliance Steering Committee: Jinoos Yazdany, MD, MPH; Zachary S. Wallace, MD, MSc; Paul Sufka, MD; Emily Sirotich, PhD; Pedro Machado, MD, PhD, FRCP; Jean Liew, MD, MS; Jonathan Hausmann, MD; Rebecca Grainger, MB ChB, PhD; Monique Gore-Massy; & Suleman Bhana, MD, FACR  |  January 11, 2023

We write to celebrate the life of Philip C. Robinson, MB ChB, PhD, FRACP, a beloved colleague and leader in rheumatology. Phil died in early January after an unexpected and short illness. He is survived by his wife, Helen, and his two young sons. We have witnessed an incredible outpouring of respect and affection for…

Filed under:Professional TopicsProfiles Tagged with:COVID-19obituaryPhilip Robinson

Patients on Dialysis Taking Denosumab May Be at Risk of Severe Hypocalcemia

Michele B. Kaufman, PharmD, BCGP  |  December 12, 2022

The FDA is investigating the risk of severe hypocalcemia with serious outcomes, such as hospitalization and death, in patients on dialysis taking denosumab.

Filed under:Drug Updates Tagged with:denosumabdialysisDrug SafetyFDAhypocalcemiaRenal diseaseU.S. Food and Drug Administration (FDA)

CORRONA: History & Lessons Learned

Joel M. Kremer, MD, MACR  |  December 9, 2022

Editor’s note: In November, the ACR honored Joel M. Kremer, MD, MACR, president of the Corrona Research Foundation, with its Distinguished Clinical Investi­gator Award for his outstanding contributions to the field of rheumatology as a clinical scientist (see story here). As the founder of the Consortium of Rheumatology Researchers of North America (CORRONA, now known…

Filed under:Drug Updates Tagged with:CorEvitasCORRONApatient registryRISE registry

Telehealth Brings Opportunities to Enhance Patient Care

Ruth Jessen Hickman, MD  |  December 8, 2022

During an ACR webinar in August, presenters discussed multiple aspects of telehealth in rheumatology, especially related to rheumatology fellowship training. They agreed that although telehealth represents one potential avenue to improve patient access to treatment for rheumatic disease, we must keep identifying the best ways to employ telehealth to enhance care. Impact of Pandemic Telemedicine…

Filed under:Information TechnologyMeeting ReportsPractice SupportTechnology Tagged with:telehealthtelemedicine

Patients Living with Chronic Illness

Thomas R. Collins  |  December 5, 2022

At ACR Convergence 2022, three women with rheumatic diseases discuss the profound life changes that the diseases wrought and ways they’ve found to cope.

Filed under:ACR ConvergenceMeeting ReportsPatient Perspective Tagged with:ACR Convergence 2022

Patients Fight Against Dark Days & Find Ways to Cope

Thomas R. Collins  |  December 2, 2022

PHILADELPHIA—Amy Gietzen started feeling the pain when she was 19. Her forearms, elbows, wrists and fingers were constantly swollen and sensitive. Six months later, she saw a doctor and was diagnosed with systemic diffuse scleroderma—a particularly hard-to-manage rheumatic disease with wide-ranging effects. Ms. Gietzen, who spoke at ACR Convergence 2022 and is a public speaker,…

Filed under:ACR ConvergenceConditionsMeeting ReportsPatient PerspectiveRheumatoid ArthritisSystemic Sclerosis Tagged with:ACR Convergence 2022self-managment

Duke Researchers Create a Type 1, Type 2 Lupus Disease Model

Catherine Kolonko  |  November 29, 2022

A new disease model for lupus tackles issues with fatigue and other serious conditions that, although quite common among patients, get less attention because they fall outside classic symptoms associated with inflammation, a debilitating force behind systemic lupus erythematosus (SLE). The model features subtypes to cate­gorize two main groups of symptoms into type 1, typically…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:fatiguelupus disease modellupus subtypes

When Rheumatic Disease May Have Affected the Course of Western Civilization

Baljeet Rai, MD, Abhimanyu Amarnani, MD, PhD, Ja-Yoon Uni Choe, MD, Nicole K. Zagelbaum Ward, DO, MPH, & Richard S. Panush, MD, MACP, MACR  |  November 8, 2022

The study of rheumatology (and medicine) in art, history, literature and music is engaging and informative.1-12 In this article, we present some instances when rheumatic and autoimmune diseases in certain individuals may have affected the course of history in Western civilization. Physicians are usually concerned, appropriately, with the effects of illness on the lives of…

Filed under:OpinionProfessional TopicsSpeak Out Rheum Tagged with:History

Speak Out Rheum: Racism’s Impact on Patient-Provider Relationships

Mia Taylor Chandler, MD, MPH  |  November 6, 2022

“I tell everyone who comes into her room now, ‘You will not disrespect my daughter again. No one will,’” recounts Sarah’s mother. “Every time a [provider] acts rude to her, Sarah tells me, ‘Ma, I’m used to it now,’ and I have to insist ‘No! Baby, you should never get used to that.’ … Dr….

Filed under:OpinionProfessional TopicsSpeak Out Rheum Tagged with:biasDisparitiesRacismSpeak Out Rheumatology

  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 97
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences